11.65 USD
+0.06 (+0.52%)
11.5516 USD
-0.1 (-0.84%)
VTRS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of VTRS while its profitability can be described as average. VTRS is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
VTRS had positive earnings in the past year.
VTRS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VTRS reported negative net income in multiple years.
Each year in the past 5 years VTRS had a positive operating cash flow.
1.2 Ratios
VTRS has a Return On Assets of -9.73%. This is in the better half of the industry: VTRS outperforms 67.02% of its industry peers.
VTRS has a better Return On Equity (-24.26%) than 63.87% of its industry peers.
VTRS's Return On Invested Capital of 3.41% is amongst the best of the industry. VTRS outperforms 80.63% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VTRS is significantly below the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| ROIC | 3.41% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
1.3 Margins
VTRS has a Operating Margin of 9.34%. This is amongst the best in the industry. VTRS outperforms 82.20% of its industry peers.
VTRS's Operating Margin has declined in the last couple of years.
VTRS has a better Gross Margin (39.36%) than 60.73% of its industry peers.
VTRS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.34% | ||
| PM (TTM) | N/A | ||
| GM | 39.36% |
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
2. Health
2.1 Basic Checks
VTRS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
VTRS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, VTRS has more shares outstanding
The debt/assets ratio for VTRS has been reduced compared to a year ago.
2.2 Solvency
VTRS has an Altman-Z score of 0.92. This is a bad value and indicates that VTRS is not financially healthy and even has some risk of bankruptcy.
VTRS's Altman-Z score of 0.92 is in line compared to the rest of the industry. VTRS outperforms 53.40% of its industry peers.
The Debt to FCF ratio of VTRS is 8.96, which is on the high side as it means it would take VTRS, 8.96 years of fcf income to pay off all of its debts.
VTRS has a Debt to FCF ratio of 8.96. This is in the better half of the industry: VTRS outperforms 79.58% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that VTRS is somewhat dependend on debt financing.
VTRS's Debt to Equity ratio of 0.82 is on the low side compared to the rest of the industry. VTRS is outperformed by 71.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 8.96 | ||
| Altman-Z | 0.92 |
ROIC/WACC0.43
WACC7.86%
2.3 Liquidity
VTRS has a Current Ratio of 1.35. This is a normal value and indicates that VTRS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.35, VTRS is not doing good in the industry: 73.30% of the companies in the same industry are doing better.
VTRS has a Quick Ratio of 1.35. This is a bad value and indicates that VTRS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.79, VTRS is not doing good in the industry: 82.20% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The earnings per share for VTRS have decreased strongly by -14.65% in the last year.
VTRS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.73% yearly.
The Revenue has decreased by -6.14% in the past year.
The Revenue has been growing slightly by 5.09% on average over the past years.
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
3.2 Future
Based on estimates for the next years, VTRS will show a small growth in Earnings Per Share. The EPS will grow by 4.45% on average per year.
Based on estimates for the next years, VTRS will show a small growth in Revenue. The Revenue will grow by 0.49% on average per year.
EPS Next Y-10.83%
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
EPS Next 5Y4.45%
Revenue Next Year-4.74%
Revenue Next 2Y-1.84%
Revenue Next 3Y-0.59%
Revenue Next 5Y0.49%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 5.00, which indicates a rather cheap valuation of VTRS.
Compared to the rest of the industry, the Price/Earnings ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 96.86% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of VTRS to the average of the S&P500 Index (26.54), we can say VTRS is valued rather cheaply.
The Price/Forward Earnings ratio is 4.62, which indicates a rather cheap valuation of VTRS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 96.34% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.78. VTRS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5 | ||
| Fwd PE | 4.62 |
4.2 Price Multiples
95.29% of the companies in the same industry are more expensive than VTRS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, VTRS is valued cheaply inside the industry as 92.15% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.33 | ||
| EV/EBITDA | 6.49 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
5. Dividend
5.1 Amount
VTRS has a Yearly Dividend Yield of 4.46%, which is a nice return.
Compared to an average industry Dividend Yield of 5.65, VTRS pays a better dividend. On top of this VTRS pays more dividend than 96.34% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, VTRS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.46% |
5.2 History
VTRS has been paying a dividend for at least 10 years, so it has a reliable track record.
VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of VTRS are negative and hence is the payout ratio. VTRS will probably not be able to sustain this dividend level.
DP-15.34%
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
11.65
+0.06 (+0.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners86.85%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change-0.14%
Market Cap13.42B
Revenue(TTM)14.12B
Net Income(TTM)-3.69B
Analysts71.76
Price Target12.38 (6.27%)
Short Float %2.04%
Short Ratio2.83
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.46% |
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-15.34%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.6%
Min EPS beat(2)5.83%
Max EPS beat(2)9.36%
EPS beat(4)3
Avg EPS beat(4)2.01%
Min EPS beat(4)-7.28%
Max EPS beat(4)9.36%
EPS beat(8)4
Avg EPS beat(8)1.01%
EPS beat(12)7
Avg EPS beat(12)1.49%
EPS beat(16)10
Avg EPS beat(16)1.8%
Revenue beat(2)2
Avg Revenue beat(2)1.72%
Min Revenue beat(2)1.3%
Max Revenue beat(2)2.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)2.14%
Revenue beat(8)2
Avg Revenue beat(8)-1.25%
Revenue beat(12)2
Avg Revenue beat(12)-1.88%
Revenue beat(16)2
Avg Revenue beat(16)-2.17%
PT rev (1m)3.36%
PT rev (3m)10%
EPS NQ rev (1m)-1.09%
EPS NQ rev (3m)-1.94%
EPS NY rev (1m)1.34%
EPS NY rev (3m)1.51%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)2.3%
Revenue NY rev (1m)1.42%
Revenue NY rev (3m)1.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5 | ||
| Fwd PE | 4.62 | ||
| P/S | 0.95 | ||
| P/FCF | 8.33 | ||
| P/OCF | 6.77 | ||
| P/B | 0.88 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.49 |
EPS(TTM)2.33
EY20%
EPS(NY)2.52
Fwd EY21.65%
FCF(TTM)1.4
FCFY12.01%
OCF(TTM)1.72
OCFY14.78%
SpS12.26
BVpS13.21
TBVpS-6.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number26.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| ROCE | 4.32% | ||
| ROIC | 3.41% | ||
| ROICexc | 3.53% | ||
| ROICexgc | 14.83% | ||
| OM | 9.34% | ||
| PM (TTM) | N/A | ||
| GM | 39.36% | ||
| FCFM | 11.41% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
ROICexc(3y)4.16%
ROICexc(5y)3.64%
ROICexgc(3y)17.86%
ROICexgc(5y)17.54%
ROCE(3y)5.12%
ROCE(5y)4.54%
ROICexgc growth 3Y-9.04%
ROICexgc growth 5Y-13.17%
ROICexc growth 3Y4.9%
ROICexc growth 5Y-4.57%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
F-Score4
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 8.96 | ||
| Debt/EBITDA | 3.05 | ||
| Cap/Depr | 13.37% | ||
| Cap/Sales | 2.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.4% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 0.92 |
F-Score4
WACC7.86%
ROIC/WACC0.43
Cap/Depr(3y)14.64%
Cap/Depr(5y)17.2%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
EPS Next Y-10.83%
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
EPS Next 5Y4.45%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
Revenue Next Year-4.74%
Revenue Next 2Y-1.84%
Revenue Next 3Y-0.59%
Revenue Next 5Y0.49%
EBIT growth 1Y-2.47%
EBIT growth 3Y-4.1%
EBIT growth 5Y1.89%
EBIT Next Year-5.05%
EBIT Next 3Y0.82%
EBIT Next 5Y1.31%
FCF growth 1Y-20.35%
FCF growth 3Y-7.94%
FCF growth 5Y6.95%
OCF growth 1Y-19.49%
OCF growth 3Y-8.61%
OCF growth 5Y5.01%
VIATRIS INC / VTRS FAQ
What is the ChartMill fundamental rating of VIATRIS INC (VTRS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to VTRS.
Can you provide the valuation status for VIATRIS INC?
ChartMill assigns a valuation rating of 7 / 10 to VIATRIS INC (VTRS). This can be considered as Undervalued.
What is the profitability of VTRS stock?
VIATRIS INC (VTRS) has a profitability rating of 5 / 10.
Can you provide the financial health for VTRS stock?
The financial health rating of VIATRIS INC (VTRS) is 3 / 10.
Can you provide the expected EPS growth for VTRS stock?
The Earnings per Share (EPS) of VIATRIS INC (VTRS) is expected to decline by -10.83% in the next year.